• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / The Impact of Low Preoperative Albumin on Short-term Outcomes after Bariatric Surgery

The Impact of Low Preoperative Albumin on Short-term Outcomes after Bariatric Surgery

Amlish B Gondal, MD, Matthew E Mobily, MD, MPH, Iman Ghaderi, MD, MSc, MHPE. University of Arizona

Introduction: Obesity and malnutrition often coexist; malnutrition in turn is an established risk factor for adverse outcomes after surgery. Preoperative albumin is routinely used as surrogate parameter for nutritional status prior to surgery. The aim of this study was to assess the effect of low preoperative albumin on outcomes within 30 days after bariatric surgery.

Methods: An observational study of patients undergoing primary sleeve gastrectomy (SG) and gastric bypass (GB) from the MBSAQIP® PUF 2016 was performed. Chi-square and two tailed t-test analyses were used for categorical and continuous outcomes, respectively, with p<0.05 denoting statistical significance. Logistic regression analysis was performed and odds ratio (OR)along with 95% confidence intervals (CI) were calculated for significant risk factors for Clavien category IV (CD-IV), category V (CD-V) and composite infection rate (CIR) (defined as occurrence of any of the following: pneumonia, superficial SSI, deep SSI, UTI, sepsis, septic shock or clostridium difficile infection) after bariatric surgery.

Results: A totla of 106526 patients were included, 79.7% were female, 73.8% were white, and mean preoperative BMI was 44.3± 13.7 kg/m2. SG was performed in 72% in the patients and 28% patients underwent GB. Ten percent patients (n=11559) had low preoperative albumin (<3.5 g/dL) where the rest had normal albumin. The group with low and normal albumin had comparable baseline demographics and distribution of comorbidities.

When compared to patients with normal albumin, patients with low albumin experienced higher rates of Clavien category V complication (0.2% vs 0.08%, p<0.001), Clavien category IV complications (1.3% vs 0.8%, p<0.001), composite infection rate (2% vs 1.4%, p<0.001) and 30-day readmission rate (5.3%, 3.8%, p<0.01). Those with low preoperative albumin also had a longer length of hospital stay (1.9± 1.7 vs. 1.6±1.2 days). On logistic regression, low preoperative albumin was associated with higher odds of Clavien category V complications (OR= 2.2, CI= 1.4-3.5, p<0.001), Clavien category IV complications (OR= 1.4, CI= 1.1-1.6, p<0.001), and any-cause infection (OR=1.3, CI=1.1-1.6). The regression models had good calibration tested through Hosmer- Lemeshow goodness-of-fit test (for CD-V: χ2 =10.8, p= 0.21; for CD-IV: χ2 =6.8, p= .55; for CIR: χ2 = 3.5, p= 0.89). Figure 1 demonstrates the discriminatory capacity of regression models for CD-V, CD-IV and CIR.

Conclusion: Preoperative albumin levels below 3.5 g/dL are a significant risk factor for serious short term-morbidity after primary bariatric surgery. Further research should focus on nutritional risk stratification and rehabilitation of patients prior to bariatric surgery.

Figure 1: Receiver operating characteristic curves for the models used for A) Clavien category V complication (c- statistic= 0.793); B) Clavien category IV complication (c- statistic= 0.694); C) Any cause infection (c- statistic= 0.630)


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 95784

Program Number: P110

Presentation Session: Poster Session (Non CME)

Presentation Type: Poster

View this Poster

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search